Non-Therapeutic Biomolecules Market Expected To Reach $56.42 Billion By 2030 As Growth Accelerates At 10.7% CAGR
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Non-Therapeutic Biomolecules Market Expansion From $37.58 Billion In 2026 To $56.42 Billion In 2030
The market for non-therapeutic biomolecules has experienced rapid expansion over the past few years. By 2025, its size is projected to reach $33.92 billion, and it is expected to climb to $37.59 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.8%. Several factors drove this historic growth, such as a growing requirement for research biomolecules, heightened usage in in vitro diagnostics, an uptick in pharmaceutical research, progress in recombinant protein technology, and an increase in partnerships among biotechnology companies.
The non-therapeutic biomolecules sector is projected to experience rapid expansion over the coming years. By 2030, its valuation is forecasted to reach $56.43 billion, reflecting a compound annual growth rate (CAGR) of 10.7%. This anticipated increase during the forecast period is driven by factors such as the broadening scope of synthetic biomolecule uses, heightened investment in precision medicine, greater adoption in agricultural biotechnology, an intensified emphasis on sustainable and scalable production processes, and advancements in automated systems for biomolecule synthesis. Key trends shaping this period involve sophisticated protein engineering, high-throughput screening tools, eco-friendly biomolecule manufacturing, cell-free synthesis methods, and the emergence of adaptable biomolecule platforms.
Download A Free Sample Report For Comprehensive Market Insights:
Non-Therapeutic Biomolecules Market Development Factors: Which Trends Are Supporting Demand?
A surge in research activities and laboratory testing is anticipated to drive the expansion of the non-therapeutic biomolecules market in the coming years. Laboratory testing involves medical procedures where samples such as blood or urine are analyzed to diagnose diseases, monitor health conditions, and develop treatment plans, while research entails creating new knowledge or applying existing knowledge innovatively to generate fresh concepts and understandings. In laboratory testing, non-therapeutic biomolecules are employed to detect or quantify biomarker molecules indicative of disease, thereby improving test sensitivity and specificity. For example, in July 2024, the National Health Service (NHS), a healthcare provider in the UK, reported that diagnostic activity exceeded pre-pandemic levels in 2023, with a 21% rise in tests performed in May 2024 compared to the previous year. Consequently, the rapid increase in research and laboratory testing is fueling growth in the non-therapeutic biomolecules market.
Non-Therapeutic Biomolecules Market Segments: Where Are The Largest Growth Opportunities?
The non-therapeutic biomolecules market covered in this report is segmented –
1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies
2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)
3) By Application: Diagnostic Equipment, Therapeutic Equipment, Monitoring Or Imaging Equipment, Laboratory Or Research Equipment, Rehabilitation Or Mobility Support
Subsegments:
1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes
2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors
3) By Plasmids: Research Plasmids, Expression Plasmids
4) By Peptides: Antimicrobial Peptides, Signaling Peptides
5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides
6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies
Non-Therapeutic Biomolecules Market Transformation Trends: Which Innovations Are Driving Change?
Leading players in the non-therapeutic biomolecules sector are actively advancing novel cell separation technologies aimed at boosting throughput and refining processes, thereby securing a competitive edge. This exclusive research-only kit is designed to address critical biological and lab workflow challenges faced by scientists. For example, in May 2023, AcouSort AB, a biotechnology firm based in Sweden, introduced the AcouTrap 3 system. By merging acoustofluidics—where sound waves are integrated with microfluidics—this system provides an efficient approach for isolating cells and extracellular vesicles within a single workflow. Leveraging gentle acoustic trapping technology, the AcouTrap 3 enables researchers to process increased sample volumes while achieving superior cell viability and reduced loss when compared to conventional column- or bead-based methods, thus enhancing productivity and streamlining laboratory functions.
Non-Therapeutic Biomolecules Market Major Participants And Competitive Dynamics
Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Eppendorf AG, Bio-Techne Corporation, Vectalys, Avid Bioservices Inc.
Access The Complete Non-Therapeutic Biomolecules Market Report:
Non-Therapeutic Biomolecules Market Leading Geography: Which Region Generates The Most Revenue?
Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2025. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
